Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Rauscher, Gregory E., M.D. PA

Status: Unknown

Conditions: Pancreatic Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01994681

00004108

Details and patient eligibility

About

Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven Pancreatic cancer.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Pancreatic cancer Group

Inclusion Criteria:

• Age from 18 years old
• Pancreatic cancer positive biopsy
• Before any treatment
• Signed Informed Patient Consent

Exclusion Criteria:

• Age under 18 years old
• Neoadjovant treatment
• Post surgery for Pancreatic cancer
• A history of any other cancer type, except skin cancer that is not melanoma

Healthy Group

Inclusion Criteria:

• Healthy patients
• No history of Pancreatic cancer
• Signed Informed Patient Consent

Exclusion Criteria:

• History of Pancreatic cancer
• Pancreatic cancer background in the family
• A history of any other cancer type, except skin cancer that is not melanoma

Trial design

100 participants in 2 patient groups

Pancreatic Cancer

Healthy